期刊文献+

急性脑血管病患者血清超敏C反应蛋白和心肌酶变化分析 被引量:4

Analysis the Changes Hs-CRP and Myocardial Enzymes in Patients with Acute Cerebrovascular Disease
下载PDF
导出
摘要 目的探讨急性脑血管病患者(脑出血、脑梗死)血清超敏C反应蛋白(hs-CRP)和心肌酶谱(AST、LDH、CK、CK-MB)含量变化及临床意义。方法对121例急性脑血管病患者和58例健康体检者进行血清hs-CRP和心肌酶谱水平的检测。结果脑出血组和脑梗死组血清中hs-CRP、心肌酶的水平明显高于健康对照组(P<0.01),脑出血组和脑梗死组之间比较差异无统计学意义(P>0.05),有意识障碍组和无意识障碍组比较差异有统计学意义(P<0.01)。结论急性脑血管病患者血清hs-CRP和心肌酶水平明显升高,其检测水平与疾病的性质无关,与病情严重程度一致,对这些指标的检测有助于判断病情的进展和预后。 Objective To discuss the changes and clinical significane of high sensitivity C reactive protein(hs-CRP)and myocardial enzymes(AST.LDH.CK.CK-MB)in patients with acute cerebrovaseular disease(cerebral hemorrhage.cerebral infarction). Methods To dectect hs-CRP and myocardial enzymes in 121 patients with acute cerebrovascular disease and 58 healthy subjects. Results Compared with the control group, hs-CRP and myocardial enzymes in the patient group were significantly higher(P〈 0. 01) , there was no significant difference in hs-CRP and myocardial enzymes between the cerebral hemorrhage group and cerebral infarction group(P〉0.05). There was a significant difference in hs-CRP and myocardial enzymes between the conscious disturbance group and the unconscious disturbance group(P〈0.01). Conclusion There was a significant development in hs-CRP and my ocardial enzymes in patients with acute cerebrovascular disease. The concentration was not related to the character of diease, but it was consistent with the severity of diease. It will contribute to the development estimation and prognosis valuation for the acute ce- rebrovascular disease.
出处 《国际检验医学杂志》 CAS 2010年第9期962-963,共2页 International Journal of Laboratory Medicine
关键词 脑血管障碍 C反应蛋白质 心肌酶谱 cerebrovascular disorders C-reactive protein myocardial enzymes
  • 相关文献

参考文献5

二级参考文献33

共引文献36

同被引文献24

  • 1张大创,殷建明,罗陆一,张卫斌,黄梦雨,赵珊珊.通脉地仙丸对不稳定型心绞痛患者血清hs-CRP、Hcy的影响[J].中国中医药科技,2009,16(6):437-438. 被引量:2
  • 2卢斌,田仁发.脑血管疾病急性期心肌酶与肌钙蛋白变化的临床意义[J].西部医学,2005,17(6):585-586. 被引量:10
  • 3蔡蓉 高艳虹.C反应蛋白与人类总死亡率、心血管疾病死亡率以及心血管危险因素的关系[J].国外医学:心血管疾病分册,2001,28(5):312-313.
  • 4Devara JS? Xu DY, Jialal 1. C-reactive protein increasesplasminogen activator inhibitor-1 experession and activityin human aortic endothelial cells : implications for themetabobiic syndrome and atherothrombosis[J]. Circula-tion,2003,107(5) :398-400.
  • 5Verma S? Li SH, Badiwala MV,et al. Endothelin antago-nism and interleukin-6 inhibitions attenuate the proathero-genic effects of C-reactive protein[J]. Circulation,2002,105(3):1890-1896.
  • 6Maseri A. Inflammation, atherosclerosis, and ischemic e-vents exploring the hidden side of the moon[_Jj. N Engi JMed, 1997,336(11) :1014-1016.
  • 7Ridker PM, Cushman M, Stampfer MJ, et al. Inflamma-tion,aspirin,and the risk of cardiovascular disease in ap-parently healthy men[J]. N Engl J Med, 1997,336(14):973-979.
  • 8Agewall S, Wikstrand J . Fagerberg B. Prothrombin frag-ment 1 + 2 is a risk factor for myocardial infarction intreated hypertensive men [J j. Hypertens, 1998, 16 (4 );537-541.
  • 9陈小娟;李君良;赵斌.急性脑出血患者心肌酶谱的变化[J]{H}中华医学实践杂志,2004(06):488-489.
  • 10赵佳,吴爱明,张妍,任毅,邹忆怀.中风病高敏C反应蛋白变化与中医证候的相关性研究[J].北京中医药大学学报(中医临床版),2009,16(2):13-16. 被引量:4

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部